Kim NJ, Vutien P, Berry K, Ioannou GN, et al. Hepatocellular carcinoma risk declines but remains high enough for screening in
the first 7 years after HCV cure with DAAs in patients with cirrhosis or high
FIB-4. Gastroenterology 2022 Jun 28. pii: S0016-5085(22)00681.
PMID: 35777481